Antibody-mediated Rejection Clinical Trials in Richmond, Virginia
3 recruitingRichmond, Virginia
Showing 1–3 of 3 trials
Recruiting
Phase 2
Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation
Kidney TransplantationAMRAntibody-mediated Rejection+1 more
Alexion Pharmaceuticals, Inc.45 enrolled55 locationsNCT06744647
Recruiting
Phase 2
A Study to Evaluate the Safety and Tolerability of Efgartigimod PH20 SC Given by Prefilled Syringe in Kidney Transplant Recipients With Antibody-Mediated Rejection (AMR)
Antibody-mediated Rejection
argenx30 enrolled23 locationsNCT06503731
Recruiting
Phase 3
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR)
Antibody-mediated Rejection
Biogen120 enrolled59 locationsNCT06685757